Lachno, D Richard <br/><br/>
Validation of assays for measurement of amyloid-β peptides in cerebrospinal fluid and plasma specimens from patients with Alzheimer's disease treated with solanezumab.  [electronic resource] 

 -  Journal of Alzheimer's disease : JAD  2013 
 - 897-910 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1875-8908 
<br/><br/><label>Standard No.: </label>10.3233/JAD-122317  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alzheimer Disease--blood<br/>Amyloid beta-Peptides--blood<br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Antipsychotic Agents--therapeutic use<br/>Biotinylation<br/>Calibration<br/>Enzyme-Linked Immunosorbent Assay<br/>Female<br/>Humans<br/>Linear Models<br/>Male<br/>Peptide Fragments--blood<br/>Reference Values<br/>Reproducibility of Results<br/>Time Factors